title: Clinically silent Crohn's disease in a patient with Takayasu's arteritis unresponsive to conventional therapies.
abstract: Takayasu arteritis (TA) and Crohn's disease (CD) are chronic inflammatory diseases with granulomatous nature. Here, we report a case of TA with a silent course of CD who was refractory to corticosteroid and immunosuppressive treatments and improved with adalimumab therapy.
authors.affiliation: Department of Rheumatology, Faculty of Medicine, Marmara University, Fevzi Cakmak Mah, Ust Kaynarca / Pendik, Istanbul, Turkey, dr.yilmazneslihan@gmail.com.
authors.forename: Neslihan
authors.initials: N
authors.lastname: Yilmaz
authors.forename: Meryem
authors.initials: M
authors.lastname: Can
authors.forename: Fatma
authors.initials: F
authors.lastname: Alibaz-Oner
authors.forename: Haner
authors.initials: H
authors.lastname: Direskeneli
mesh_terms: D000068879:Adalimumab; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D003113:Colonoscopy; D015897:Comorbidity; D003424:Crohn Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D013625:Takayasu Arteritis / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology*; D017211:Treatment Failure; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors; D055815:Young Adult
chemical_list: D000305:Adrenal Cortex Hormones; D061067:Antibodies, Monoclonal, Humanized; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab